Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11857637 Anti-CD25 antibody-maytansine conjugates and methods of use thereof

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

David Rabuka0

Penelope M. Drake0

Date of Patent

January 2, 2024

0

Patent Application Number

175191830

Date Filed

November 4, 2021

0

Patent Citations

US Patent 11097013 Anti-HER2 antibody-maytansine conjugates and methods of use thereof

0

US Patent 10745464 Aldehyde tags, uses thereof in site-specific protein modification

0

US Patent 10888623 Hydrazinyl-indole compounds and methods for producing a conjugate

0

US Patent 7985783 Aldehyde tags, uses thereof in site-specific protein modification

0

US Patent 8097701 Aldehyde tags, uses thereof in site-specific protein modification

0

US Patent 8349910 Aldehyde tags, uses thereof in site-specific protein modification

0

US Patent 8729232 Aldehyde tags, uses thereof in site-specific protein modification

0

US Patent 8846866 Aldehyde tags, uses thereof in site-specific protein modification

0

...

Patent Primary Examiner

Karen A. Canella

0

CPC Code

0

0

0

0

0

Patent abstract

The present disclosure provides anti-CD25 antibody-maytansine conjugate structures. The disclosure also encompasses methods of production of such conjugates, as well as methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11857637 Anti-CD25 antibody-maytansine conjugates and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool